I do think Alzheimer's is much bigger than we think. Having a diagnostic and a therapeutic will generate massive interest from BP beyond CLIA partner. The deal there could be multiple times bigger than CLIA partner. Also, TBI/CTE could be in play for Lympro very soon and may align with the Summit.